The global synthetic biology market is growing, due to growing support of government organizations, and growing geriatric population. In addition, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R & D investments in drug discovery and development are also supporting the growth of this market.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/synthetic-biology-market/report-sample
The growing support of government organizations and growing geriatric population are playing a pivotal role in the growth of this market. Some of the major organizations include the National Science Foundation (NSF), the National Aeronautics and Space Administration (NASA), the Center for Chemical and Synthetic Biology (CCSB), the Synthetic Biology Engineering Research Center (SynBERC), and the International Association Synthetic Biology (IASB). These organizations are providing support in the form of funding, and initiatives implemented by them for their respective goals.
Additionally, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R & D investments in drug discovery and development are also supporting the growth of this market. However, stringent regulatory requirements, expensive research procedures, and harmful effects of synthetic biology act as hindrance in the growth of the global market. The growing number of mergers and acquisitions is one of the latest trends in this market.
The key companies operating in the global synthetic biology market include EI from Pont de Nemours and Company, Amyris Inc., GenScript USA Inc., Intrexon Corporation, Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Royal DSM, Novozymes A / S, New England Biolabs Inc. and Integrated DNA Technologies Inc.
Source: P & S Intelligence